424 related articles for article (PubMed ID: 17708420)
1. Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2.
Botta A; Vallo L; Rinaldi F; Bonifazi E; Amati F; Biancolella M; Gambardella S; Mancinelli E; Angelini C; Meola G; Novelli G
Gene Expr; 2007; 13(6):339-51. PubMed ID: 17708420
[TBL] [Abstract][Full Text] [Related]
2. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of CUGBP1 in skeletal muscle from adult classic myotonic dystrophy type 1 but not from myotonic dystrophy type 2.
Cardani R; Bugiardini E; Renna LV; Rossi G; Colombo G; Valaperta R; Novelli G; Botta A; Meola G
PLoS One; 2013; 8(12):e83777. PubMed ID: 24376746
[TBL] [Abstract][Full Text] [Related]
4. Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells.
Buj-Bello A; Furling D; Tronchère H; Laporte J; Lerouge T; Butler-Browne GS; Mandel JL
Hum Mol Genet; 2002 Sep; 11(19):2297-307. PubMed ID: 12217958
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2.
Santoro M; Masciullo M; Bonvissuto D; Bianchi ML; Michetti F; Silvestri G
Mol Cell Biochem; 2013 Aug; 380(1-2):259-65. PubMed ID: 23666741
[TBL] [Abstract][Full Text] [Related]
6. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
Cho DH; Tapscott SJ
Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
[TBL] [Abstract][Full Text] [Related]
7. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.
Tang ZZ; Yarotskyy V; Wei L; Sobczak K; Nakamori M; Eichinger K; Moxley RT; Dirksen RT; Thornton CA
Hum Mol Genet; 2012 Mar; 21(6):1312-24. PubMed ID: 22140091
[TBL] [Abstract][Full Text] [Related]
8. Altered expression and splicing of Ca(2+) metabolism genes in myotonic dystrophies DM1 and DM2.
Vihola A; Sirito M; Bachinski LL; Raheem O; Screen M; Suominen T; Krahe R; Udd B
Neuropathol Appl Neurobiol; 2013 Jun; 39(4):390-405. PubMed ID: 22758909
[TBL] [Abstract][Full Text] [Related]
9. Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes.
Kim EY; Barefield DY; Vo AH; Gacita AM; Schuster EJ; Wyatt EJ; Davis JL; Dong B; Sun C; Page P; Dellefave-Castillo L; Demonbreun A; Zhang HF; McNally EM
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30730308
[TBL] [Abstract][Full Text] [Related]
10. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.
Charlet-B N; Savkur RS; Singh G; Philips AV; Grice EA; Cooper TA
Mol Cell; 2002 Jul; 10(1):45-53. PubMed ID: 12150906
[TBL] [Abstract][Full Text] [Related]
11. RNA pathogenesis of the myotonic dystrophies.
Day JW; Ranum LP
Neuromuscul Disord; 2005 Jan; 15(1):5-16. PubMed ID: 15639115
[TBL] [Abstract][Full Text] [Related]
12. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
Cardani R; Mancinelli E; Rotondo G; Sansone V; Meola G
Eur J Histochem; 2006; 50(3):177-82. PubMed ID: 16920640
[TBL] [Abstract][Full Text] [Related]
13. Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2.
Vihola A; Bachinski LL; Sirito M; Olufemi SE; Hajibashi S; Baggerly KA; Raheem O; Haapasalo H; Suominen T; Holmlund-Hampf J; Paetau A; Cardani R; Meola G; Kalimo H; Edström L; Krahe R; Udd B
Acta Neuropathol; 2010 Apr; 119(4):465-79. PubMed ID: 20066428
[TBL] [Abstract][Full Text] [Related]
14. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubes.
Santoro M; Piacentini R; Masciullo M; Bianchi ML; Modoni A; Podda MV; Ricci E; Silvestri G; Grassi C
Neuropathol Appl Neurobiol; 2014 Jun; 40(4):464-76. PubMed ID: 23888875
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of muscle atrophy in myotonic dystrophies.
Timchenko L
Int J Biochem Cell Biol; 2013 Oct; 45(10):2280-7. PubMed ID: 23796888
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy.
Osborne RJ; Lin X; Welle S; Sobczak K; O'Rourke JR; Swanson MS; Thornton CA
Hum Mol Genet; 2009 Apr; 18(8):1471-81. PubMed ID: 19223393
[TBL] [Abstract][Full Text] [Related]
18. Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy.
Lueck JD; Mankodi A; Swanson MS; Thornton CA; Dirksen RT
J Gen Physiol; 2007 Jan; 129(1):79-94. PubMed ID: 17158949
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy.
Ho TH; Bundman D; Armstrong DL; Cooper TA
Hum Mol Genet; 2005 Jun; 14(11):1539-47. PubMed ID: 15843400
[TBL] [Abstract][Full Text] [Related]
20. Comparative transcriptional and biochemical studies in muscle of myotonic dystrophies (DM1 and DM2).
Salvatori S; Furlan S; Fanin M; Picard A; Pastorello E; Romeo V; Trevisan CP; Angelini C
Neurol Sci; 2009 Jun; 30(3):185-92. PubMed ID: 19326042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]